NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Sharma, Ram V ^a   Tan, Enqing ^a   Fang, Shengyun ^a   Gurjar, Milind V ^a   Bhalla, Ramesh C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adenovirus mediated gene transfer; Coronary arteries; Cyclins; Endothelial nitric oxide synthase; Proliferating cell nuclear antigen; 3H thymidine incorporation

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; GENE TRANSFER; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; VASCULAR SMOOTH MUSCLE;

EID: 0032993545     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.5.h1450     Document Type: Article

References (35)

1. Abe, J., W. Zhou, N. Tagkuwa, K. Miki, H. Okazaki, K. Kurokawa, M. Kumada, and Y. Takuwa. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery. Biochem. Biophys. Res. Commun. 198: 16-24, 1994.
2. Bhalla, R. C., K. F. Toth, R. A. Bhatty, L. P. Thompson, and R. V. Sharma. Estrogen treatment attenuates proliferation and agonist-induced calcium responses in cultured coronary artery smooth muscle cells. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H1996-H2003, 1997.
3. Bowen-Pope, D. F., and R. Ross. Methods for studying the platelet-derived growth factor receptor. Methods Enzymol. 109: 69-100, 1988.
4. Bush, P.A., N. E. Gonzalez, and L. J. Ignarro. Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. Biochem. Biophys. Res. Commun. 186: 308-314, 1992.
5. Chang, M. W., E. Barr, M. M. Lu, K. Barton, and J. M. Leiden. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96: 2260-2268, 1995.
6. Chang, M. W., E. Barr, J. Seltzer, Y. Jiang, G. J. Nabel, E. G. Nabel, M. S. Paramacek, and J. M. Leiden. Cytostatic gene therapy for vascular proliferation disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 2260-2268, 1995.
7. Kip1 for restriction point control of the filbroblast cell cycle. Science 272: 877-880, 1996.
8. Dixon, B. S., R. V. Sharma, and M. J. Dennis. The bradykinin B2 receptor is a delayed early response gene for platelet-derived growth factor in arterial smooth muscle cells. J. Biol. Chem. 271: 13324-13332, 1996.
9. Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-1672, 1996.
10. Fang, S., R. V. Sharma, and R. C. Bhalla. Endothelial nitric oxide synthase gene transfer inhibits platelet-derived growth factor-BB stimulated focal adhesion kinase and paxillin phosphorylation in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 236: 706-711, 1997.
11. Fang, S., R. V. Sharma, and R. C. Bhalla. Enhanced recovery of injury-caused down-regulation of paxillin protein by eNOS gene expression in rat carotid artery: a mechanism of NO inhibition of intima hyperplasia. Arterioscler. Thromb. Vasc. Biol. 19: 147-152, 1999.
12. Grana, X., and E. P. Reddy. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (cdks), growth suppresser genes and cyclin-dependent kinase inhibitor (CDKIs). Oncogene 11: 211-219, 1995.
13. Gunn, J., C. M. Holt, S. E. Francis, L. Shepherd, M. Grohmann, Newman C. M. H., D. C. Crossman, and D. C. Cumberland. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty. Circ. Res. 80: 520-531, 1997.
14. Guo, J. P., M. M. Panday, P. M. Consigny, and A. M. Lefer. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimai injury. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1122-H1311, 1995.
15. Ho, Y. S., Y. J. Wang, and J. K. Lin. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinog. 16: 20-31, 1996.
16. Sdi1/Cip1/Waf1 by nitric oxide generating vasodilator in vascular smooth muscle cells. J. Biol. Chem. 272: 10050-10057, 1997.
17. McNmara, D. B., B. Bedi, H. Aurora, L. Tena, L. J. Ignarro, P. J. Kadowitz, and D. L. Akers. L-Arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 193: 291-296, 1993.
18. Mooradian, D. L., T. C. Hutsell, and L. K. Keefer. Nitric oxide (NO) donor molecules: effects of NO release rate on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol. 25: 674-678, 1995.
19. Morgan, D. O. Principles of CDK regulation. Nature 374: 131-134, 1995.
20. Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, H. von der Leyen, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. Clin. Invest. 93: 1458-1464, 1994.
21. Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA 90: 8474-8478, 1993.
22. Nishida, K., D. G. Harrison, J. P. Navas, A. A. Fisher, S. P. Dockery, M. Uematsu, R. M. Nerem, R. W. Alexander, and T. J. Murphy. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90: 2092-2096, 1992.
23. Ooboshi, H., Y. Chu, C. D. Rios, F. M. Faraci, B. L. Davidson, and D. D. Heistad. Altered vascular function after adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H265-H270, 1997.
24. Ross, R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57: 791-804, 1995.
25. Rubanyi, G. M. The role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 2, Suppl. 4: S1-S14, 1993.
26. Sarkar, R., E. G. Meinberg, J. C. Stanley, D. Gordon, and R. C. Webb. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78: 225-30, 1996.
27. Schwartz, R. S., D. R. Holmes, and E. J. Topol. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J. Am. Coll. Cardiol. 20: 1374-1387, 1992.
28. Scott-Burden, T., and P. M. Vanhoutte. Regulation of smooth muscle cell growth by endothelium-derived factors. Tex. Heart Inst. J. 21: 91-97, 1994.
29. Sharma, R. V., and R. C. Bhalla. PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells. Am. J. Physiol. 264 (Cell Physiol. 33): C71-C79, 1993.
30. Sharma, R. V., S. Fang, and R. C. Bhalla. Factors influencing adenovirus-mediated gene transfer to endothelial and vascular smooth muscle cells in-vivo and in-vitro. In: Recent Research Developments in Molecular Biology, edited by S. G. Pandalai. Trivandrum, India: Research Signpost, 1997, p. 41-50.
31. Sharma, R. V., S. Fang, E. Q. Tan, H. Ooboshi, and R. C. Bhalla. Adenovirus-mediated eNOS gene transfer in coronary artery VSM cells inhibits migration and proliferation (Abstract). FASEB J. 11: 552A, 1997.
32. Tanner, F. C., Z.-Y. Yang, E. Duckers, D. Gordon, G. J. Nabel, and E. G. Nabel. Expression of cyclin dependent kinase inhibitors in vascular disease. Circ. Res. 82: 396-403, 1998.
33. Toyoshima, H., and T. Hunter. P27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994.
34. Von der Leyen, H. E., G. H. Gibbons, R. Morishita, N. P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J. P. Cooke, and V. J. Dzau. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA 92: 1137-1141, 1995.
35. Wei, G. L., K. Krasinski, M. Kearney, J. M. Isner, K. Walsh, and V. Andres. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ. Res. 80: 418-426, 1997.